Tesla shares fell close to 4% Wednesday as reports indicated the electric vehicle maker's sales continued to slip in some key markets last month.

Akebia Therapeutics had a strong US launch of Vafseo and Q1 revenues signal robust demand, but near-term profitability ...

The merger between Chart Industries and Flowserve is a strategic succession move. The merger's true value lies in expanded ...